Think of Nesina as a "Me Too" Similar to Januvia, Onglyza, and Trajenta

Nesina (nes-SEE-nah, alogliptin) will compete in a crowded market of gliptins, or DPP-4 inhibitors, for type 2 diabetes.

It's a "me too"...similar to Januvia (sitagliptin), Onglyza (saxagliptin), and Trajenta (linagliptin).

Continue to recommend lifestyle changes and metformin first.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote